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Abstract  
A general understanding of interactions between DNA and oppositely charged 
compounds forms the basis for developing novel DNA-based materials, including gel 
particles. The association strength, which is altered by varying the chemical structure of 
the cationic cosolute, determines the spatial homogeneity of the gelation process, 
creating DNA reservoir devices and DNA matrix devices that can be designed to release 
either single- (ssDNA) or double-stranded (dsDNA). This review covers recent 
developments on the topic of DNA gel particles formed in water–water emulsion-type 
interfaces. The degree of DNA entrapment, particle morphology, swelling/dissolution 
behaviour and DNA release responses are discussed as a function of the nature of the 
cationic agent used. On the basis of designing DNA gel particles for therapeutic 
purposes, recent studies on the determination of the surface hydrophobicity, the 
haemolytic and the cytotoxic assessments of the obtained DNA gel particles have been 
also reported. 
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1. Introduction 
The main aim of the gene therapy is to transfer genetic material into the cells to 
cure diseases through the expression of certain proteins. Despite significant advances in 
the past couple of decades, gene therapy is still in the clinical trial stage, mainly due to 
the lack of safe and efficient delivery vehicles for therapeutic nucleic acids. 
Deoxyribonucleic acid (DNA) is a negatively charged biomacromolecule that is subject 
to degradation in the bloodstream by endogenous nucleases [1]. Moreover, it is too large 
to cross the cellular membranes. The most common strategy employed for the 
“packaging” of DNA is based on electrostatic interaction between the anionic nucleic 
acid and the positive charges of the synthetic vector which will complex and condense 
the nucleic acid [2]. 
The rapidly rising demand for therapeutic grade DNA molecules requires associated 
improvements in encapsulation and delivery technologies. This includes the formulation 
of DNA molecules into synthetic delivery systems for enhanced cellular transformation 
efficiencies. Research works on colloidal delivery systems in genetic therapeutics are 
based on the molecular level focusing on the interdisciplinary development of 
pharmaceutical DNA delivery approaches. Colloidal delivery systems modify many 
physicochemical properties, aiming to protect the DNA from degradation, minimize 
DNA loss, prevent harmful side effects, enhance DNA targeting, increase drug 
bioavailability, and stimulate the immune systems [3-5].   
Various colloidal systems have been studied for decades improving the delivery of 
problematic DNA candidates. The most promising systems comprises of ionic 
complexes formed between DNA and polycationic liposomes [6-9]. Factors hindering 
the success of the liposomal approach appear to be instability of the complex, toxicity of 
the cationic lipid, and short half-life of the complexed DNA. Held together by 
electrostatic interaction, these complexes may dissociate because of the charge 
screening effect of the polyelectrolytes in the biological fluid. A strongly basic lipid 
composition can stabilize the complex, but such lipids may be cytotoxic. The fact that 
the DNA is coated on the outside of the liposome renders the DNA vulnerable to 
nuclease degradation in transit from site of administration to the nucleus of the target 
cell. 
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Biocompatible polymers are widely used in drug delivery and tissue engineering, 
where they form a variety structures, through either chemical cross-linking or physical 
association, that range from nanoparticles to macroscopic scaffolds [10-15]. In many 
applications, it is important to control their degradation rates, which is usually achieved 
by incorporating hydrolytically or enzymatically cleavable groups into the polymer 
structure [16-23]. Biodegradable polymer constructs can also be prepared via reversible 
physical cross-linking, where the degradation rates depend on the strength of 
electrostatic, hydrophobic, or hydrogen bonding interactions [24-27]. Both of these 
approaches to tuning the degradation rates, however, have the disadvantages of usually 
requiring the polymer to be synthetically modified. An alternative approach is to control 
the degradation rates by using a modular physical cross-linker, the association strength 
of which will govern the degradation rate of the gel. This can be achieved by exploiting 
the association between surfactants and polyelectrolytes [28].  
Oppositely charged surfactants and polyelectrolytes have a strong tendency to bind to 
one another. When the surfactant/polyelectrolyte attraction overcomes their solubility in 
the solvent, associative phase separation occurs [29-34]. This results in the formation of 
concentrated liquid, gel, or precipitate phases in equilibrium with a dilute liquid [29-37]. 
The polyelectrolyte chains can assume two types of conformations, either expanded, as 
in a solution or a hydrogel, or collapsed, such as around a surfactant aggregate as 
precipitate. Control over the transitions between these states allows exploitation of 
surfactant and polyelectrolyte mixtures in a wide array of commercial applications, such 
as drug delivery, cosmetic formulations, and rheological modification. There have 
initially been two separate reports of associative phase separation in surfactant and 
polyelectrolyte mixtures (where the polyelectrolyte undergoes a transition from an 
expanded to a collapsed state) that yields hollow surfactant/polyelectrolyte gel particles, 
with numerous potential applications in controlled encapsulation and release and 
separation processes [38-39]. This effect is achieved with a dropwise addition method 
[40-42] where drops of chitosan solutions are added to an oppositely charged surfactant 
solution [38-39]. Observations suggest that the gel formation process is diffusion 
limited, that the gel layer thickness is proportional to the amount of polyelectrolyte in 
solution, and that the gelled surfactant and polyelectrolyte complex is electroneutral 
[39].  
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This behaviour has been exploited to form gel particles by dropwise addition of 
solutions of different cellulose-based polycations (chitosan, N,N,N-trimethylammonium 
derivatized hydroxyethyl cellulose (Amerchol JR-400)) [38-39, 43-44] to anionic 
(sodium dodecyl sulfate (SDS), sodium perfluorooctanoate (FC7)) and catanionic 
(cetyltrimethylammonium bromide (C16TAB)/sodium perfluorooctanoate (FC7)) 
surfactant solutions [45].  This approach has been extended to encapsulate an aromatic 
oil in surfactant–polyelectrolyte gel particles. Its release into either aqueous or organic 
phases has been studied [46].  
A general understanding of the interactions between DNA and oppositely charged 
agents, and in particular the phase behaviour, has given us a basis for developing novel 
DNA-based materials, including gels, membranes and gel particles [47]. Concerning 
DNA gel particles, we have recently prepared novel DNA gel particles based on 
associative phase separation and interfacial diffusion. By mixing solutions of DNA 
(either single- (ssDNA) or double-stranded (dsDNA)) with solutions of different 
cationic agents, such as surfactants, proteins and polysacharides, the possibility of 
formation of DNA gel particles without adding any kind of cross-linker or organic 
solvent has been confirmed [48-51]. The association strength, which is tuned by varying 
the chemical structure of the cationic agent, allows a control of the spatial homogeneity 
of the gelation process, producing either a homogeneous DNA matrix or different DNA 
reservoir devices. 
Cationic surfactants have offered a particularly efficient control of the properties of 
these DNA-based particles [47-57]. We have initially exploited to form DNA gel 
particles at water–water emulsion-type interfaces by mixing DNA (either single- 
(ssDNA) or double-stranded (dsDNA)) with quaternary ammonium surfactants. The 
formation of a physical network in which surfactant micelles form 
polyanionic−multicationic electrostatic complexes as cross-link points seems to play an 
important role in the stabilization of DNA particles. Changes in the hydrophobic moiety 
of the surfactants affect their interaction with DNA [53-54]. The interactions of 
surfactants with DNA can also be tuned efficiently by controlling the head-group 
structure. These include surfactants with the cationic functionality based on an amino 
acid [57]. Surfactant molecules from renewable raw materials that mimic natural 
lipoamino acids are one of the preferred choices for food, pharmaceutical and cosmetic 
applications. Given their natural and simple structure, they show low toxicity and quick 
biodegradation [58]. Novel DNA gel particles, in which surfactants with the cationic 
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functionality is based on the amino acid arginine, can interact with nucleic acids to form 
biocompatible devices for the controlled encapsulation and release of DNA [55]. 
Little is known about the influence of the respective counter-ions on surfactant-DNA 
interaction. In general, oppositely charged macro-ions in solution attract each other, 
tending to form a bound complex. When separated, each macro-ion is surrounded by a 
diffuse layer of spatially confined counter-ions. Upon approach, the fixed macro-ion 
charges partially (sometimes fully) neutralize each other, allowing the release of mobile 
counter-ions into the bulk solution, thereby increasing their translational entropy. This 
scenario suggests that macro-ion association in solution is to a large extent an 
entropically driven process [59].
 
The actual contribution of counter-ion entropy to free 
energy association depends on the detailed geometries and charge distributions of the 
separated and bound macro-ions [59-61].
 
In this context, the effect of different counter-
ions on the formation and properties of DN  gel particles, by mixing DNA with the 
single-chain surfactant dodecyltrimethylammonium (DTA) has been recently 
investigated [54]. In particular, we employed, as counter-ions of this surfactant, anions 
of the two extremes in the Hofmeister series (hydrogen sulfate and trifluoromethane 
sulfonate) and two halides (chloride and bromide). The obtained results indicate that the 
degree of counter-ion dissociation from the surfactant micelles and the 
polar/hydrophobic character of the counter-ion are important parameters in the final 
properties of the particles. 
Most of the studies about the interaction between polyelectrolyte gels and oppositely 
charged surfactant systems have been carried out using single chain surfactants. 
However, most transfection lipids are not micellar [62]. Consequently, the extension of 
micelle to vesicle-forming double tail surfactants seems to be crucial. The formation of 
DNA gel particles, mixing DNA with the double chain surfactant 
didodecyldimethylammonium bromide (DDAB) has been studied [56]. DDAB–DNA 
gel particles have been shown to form ordered multi-vesicular assemblies which 
resemble the architecture of biological tissues. The characteristic sizes and shapes of the 
resulting structures strongly depend on the secondary structure of the DNA. Some 
features about the DNA–vesicle interaction involved in these particles have been 
deduced. 
The development of biodegradable, biocompatible DNA gel particles has been 
achieved using natural proteins or mixtures of proteins [52, 63-64] Lysozyme is one of 
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the main proteins in hen egg white and it has an ability to cause lysis of bacterial cells 
[65]. Lysozyme is a globular protein that has a net charge of +9 at neutral pH, and was 
initially used for the formation of DNA gel particles [52]. Protamines are positively 
charged (overall charge +21), arginine rich proteins that bind to DNA in a non-specific 
manner via electrostatic interactions. In addition, protamine sulfate has been shown to 
condense DNA [66-68] and to deliver plasmid DNA into eukaryotic cells [69]. This 
property, in addition to its longtime use in pharmaceutical formulations, makes 
protamine a promising candidate for gene delivery. Using mixtures of both proteins as 
DNA carriers, we have obtained systems totally based on biocompatible components, 
with a large degree of control over the release profile [63. 
Chitosan is a natural, biodegradable polysaccharide derived from chitin and its low 
toxicity has been well established. Chitosan has been proposed as an attractive gene 
carrier because of its high density of positive charges and its low toxicity to cells [70]. 
A number of in vitro studies showed that chitosan is a suitable material for efficient, 
non-viral gene and DNA vaccine delivery [71-73]. Novel chitosan-DNA gel particles 
have been prepared based on associative phase separation and interfacial diffusion using 
mixtures of DNA and chitosan of different molecular weight [74-75]. In particular it 
was found that the chitosan molecular weight is a good controlling parameter in the 
final properties of these DNA gel particles [74]. More recently, mixtures of chitosan 
with proteins were used as intrinsic biocompatible carriers to form DNA gel particles. 
Controlling the magnitude of the DNA release and achieving controlled release systems 
were accomplished using these ternary systems [75].  
 Table 1 summarizes the characteristics of the different DNA gel particle systems. These 
systems can represent a ‘‘bridge’’ for potential applications in the controlled encapsulation 
and release of ssDNA and dsDNA. The goal of this Review is to explore current research 
in DNA gel particles prepared by associative phase separation and interfacial diffusion. In 
the following sections, we describe the influence of the nature of the cationic agent, i.e. 
surfactant, protein or polysaccharide, on the degree of DNA entrapment, particle 
morphology, swelling/dissolution behaviour, and DNA release responses. Recent studies 
on the determination of the surface hydrophobicity, the haemolytic and the cytotoxic 
characterization of the obtained DNA gel particles have been also discussed. 
[Table 1 here] 
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2. Particle preparation 
As described above, interactions between oppositely charged surfactants and 
polyelectrolytes in aqueous solutions can lead to associative phase separation, where the 
concentrated phase assumes the form of a viscous liquid, gel, liquid crystal or 
precipitate. This behavior has been initially exploited to form DNA gel particles at 
water–water emulsion-type interfaces by mixing DNA (either single- (ssDNA) or 
double-stranded (dsDNA)) with the cationic surfactant cetyltrimetrylammonium 
bromide (CTAB) [52] .At high polyelectrolyte concentrations, droplets from DNA 
solutions instantaneously gelled into discrete particles upon contact with the 
corresponding surfactant solutions, as is depicted in Fig. 1a. The size of the resulting 
particle reflects the size of the parent drop and varies between 1 and 2 mm (Fig. 1b). 
Similar results were obtained when the cationic surfactant was substituted for a protein 
or polysaccharide molecule. All DNA gel particles were formulated using the method of 
simple complexation between molar concentrations of negative charge of the phosphate 
groups of DNA, and the positive charge of the cationic compound. Particles were 
prepared at a ratio between DNA and the different cationic compounds equal to 1, R= 
[DNA]/[C
+
]. In all cases, the DNA concentration was set to 60 mM. The choice of DNA 
concentration reflects the fact that it produces high viscosity solutions, which makes it a 
convenient system for the preparation of stable DNA gel particles [52]. 
[Fig. 1 here] 
Although the molecular details of the mechanism by which cationic carriers mediate 
DNA delivery are still poorly understood, current evidence supports the hypothesis that 
theDNA complexes enter cells by means of endocytosis. Often, the particle size ranges 
from 100 nm to higher than 1 mm, and, evidently, the efficiency of cellular uptake and 
subsequent intracellular processing, a prerequisite for effective cellular transfection, 
may well depend on particle size [76]. To address the problem of the size of the 
obtained DNA gel particles, a simple and novel method was used for the preparation of 
nano-/micro-sized DNA gel particles by nebulisation of a solution of DNA (single- or 
double-stranded) into an oppositely charged surfactant or protein solution [77]. Particles 
were prepared at a ratio between DNA and cationic agent equal to 1. In all cases, [DNA] 
was equal to 5 mM. Higher concentrations of DNA produce high viscosity solutions, 
which make them inconvenient systems for the nebulisation process. It was found that 
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the size of the initial DNAdroplets and the cationic agent are the main controlling 
parameters for the particle size (Table 2).  
 
3. Physicochemical characterization 
3.1. Degree of DNA entrapment  
 It is of major interest to characterize the degree of DNA entrapment on the DNA 
gel particles. The degree of DNA entrapment can be expressed as a function of the 
loading efficiency (LE) and loading capacity (LC) values. LE measures the amount of 
DNA that is included in the particles with respect to the total DNA, during particle 
formation. LC measures the amount of DNA entrapped inside the particles as a function 
of their weight. Characteristics of these DNA gel particles, which are formed using 
surfactants, proteins, and polysaccharides as cationic compounds, are summarized in 
Fig. 2. All values were measured in triplicate and are given as average and standard 
deviation. 
 Except in the case of the double-tail surfactant DDAB, the LE values were always 
higher than 99%, which confirms the effectiveness of DNA entrapment in cationic 
solutions derived from the assayed surfactants, proteins and polysaccharides (Fig. 2a). 
However, the entrapped DNA, as a function of the weight of the particles (LC values), 
depends on the cationic compound used (Fig 2b). The LC values obtained for 
surfactant-DNA gel particles depends on the hydrophilic and hydrophobic 
contributions. For the same type of polar head, trimethylammonium bromide type 
(CTAB and DTAB structures), the hydrophobic contribution did not have a strong 
influence on the observed LC value [53-54]. Identical LC values were obtained when 
DNA gel particles were prepared with surfactants that only differ in counter-ion 
structure (DTAB, DTAC, DTATf) [54]. However, for the same hydrophobic chain 
length, 12 carbon atoms in the hydrophobic chain (DTAB, ALA and LAM structures), 
there is a clear effect of the number of charges on the polar head. Whereas DTAB and 
LAM showed one positive charge on the polar head, the ALA structure showed two 
positive charges. Accordingly, higher the number of charges, higher the LC values [10]. 
When single and double-tail surfactants were compared (DTAB and DDAB structures), 
we can conclude that higher number of hydrophobic chains on the surfactant structure 
contributes negatively to the LC values [56].  
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 In the case of protein-DNA gel particles, the lowest LC value (0.7%) was obtained 
in particles formed with pure lysozyme LS. Interestingly, highest LC value were 
obtained for particles containing the pure protein PS or mixed systems containing the 
smallest amount of protamine sulfate PS in the mixed protein systems [63]. These 
differences could be attributed to differences in the binding characteristics of these two 
proteins, with different total charge and linear charge density: LS is a globular protein 
that has a net charge of + 9 at neutral pH, whereas PS is a highly positively charged 
linear protein with an overall charge of +21. The formation of the chitosan- DNA gel 
particles was studied using mixtures of DNA and chitosan of different molecular weight 
((Low MW chitosans of ca. 50 kDa and 150 kDa, and medium MW chitosan (400 kDa) 
[74] .The molecular weight of the polysaccharide structure did not have a clear effect on 
the LC values.   
 An indication of the structural characteristics of these DNA gel particles can be 
deduced from the amount of DNA released, when particles’ breakup is mechanically 
promoted. The percentages of DNA complexed were calculated and are summarized in 
Fig. 2c. Complexed DNA is related to the amounts of DNA in the supernatant solutions 
and the skins derived from the particles, after particles were magnetically stirred 
overnight. In the case of surfactant-DNA gel particles, the percentages of complexed 
DNA suggest that, with surfactant structures with twelve carbon atoms in the 
hydrophobic chain (DTAB, DTAC, DTATf, ALA, LAM), most of the DNA is 
complexed during the particle formation process [54-55]. More limited complexation 
has been obtained by increasing, either the alkyl chain length at to sixteen carbon atoms 
(CTAB), or the number of alkyl chains in the molecule from one to two (DDAB) [53, 
56]. In the case of the protein-DNA gel particles, the amount of complexed DNA 
increases progressively in the presence of the protein PS [63] as a consequence of the 
binding characteristics of this protein. The amount of complexed DNA in the case of 
chitosan-DNA gel particles seems to decrease when the molecular weight of the 
polysaccharide is increased [74]. A low molecular weight of chitosan promotes the 
formation of particles in which a higher percentage of DNA is complexed. The 
continuous diffusion of chitosan throughout the particles promotes the increase of the 
shell portion with time. 
 This distribution could be correlated with differences in the gelation process during 
particle formation. Homogeneous gelation can lead to homogeneous structures (solid 
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particles), whereas a more inhomogeneous gelation process forms core-shell structures 
[43]. In the present study, the model distribution of DNA in the particles was supported 
by visual inspection, since translucent core-shell particles and opaque condensed 
particles were found (Fig. 2d).  
[Fig. 2 here] 
3.2. Morphological characterization of the DNA gel particles  
 The secondary structure of the DNA molecules in the gels was studied by 
fluorescence microscopy (FM) using acridine orange staining. Acridine orange (AO) 
has been used to label nucleic acids in solution and in intact cells [78-81]. In the case of 
AO-dsDNA, the fluorescence emission shows a maximum around 530 nm, in the green 
spectra. The association with ssDNA shows a maximum around 640 nm, in the red 
spectra.  
 Based on the observation of green or red emission, AO was used to differentiate 
between native, double-stranded (dsDNA), and denatured, single-stranded (ssDNA), in 
DNA gel particles. Fig. 3a shows fluorescence micrographs of individual particles of 
the surfactant-dsDNA systems.  FM studies have revealed that the formation of 
particles with double-stranded DNA is carried out with conservation of the secondary 
structure of the DNA. However, in the case of particles formed with denatured DNA, 
green emission is also observed, except in the case of CTAB-ssDNA gel particles. The 
absence of red emission in the particles containing denatured DNA suggests that the 
accessibility of free DNA to the dye is hindered. This observation is consistent with our 
data on DNA distribution (Fig. 3b). The percentage of DNA released was less than 
0.1%, which confirms the total complexation of the DNA. However, when CTAB was 
used, the amount of ssDNA released reached 20%, making its detection possible in 
fluorescence microscopy studies.  
 Scanning electron microscopy imaging was carried out to establish possible 
differences in the morphologies between the different particles. Fig. 4 shows 
representative images of CTAB and DTAB surfactants. Clear similarities were found in 
the outer surface morphology between these four formulations. However, the surface of 
the inner structure revealed a different structure. Large pores and channel-like structures 
were found in the inner surface of particles formed with CTAB. However, the structure 
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of the particles formed with DTAB revealed a more compact structure. The structures 
obtained seem to confirm the degree of complexation between these two surfactants and 
DNA (see Fig. 3b), which increases the shell section of the obtained particles.  
[Fig. 3 here] 
[Fig. 4 here] 
 Similar experiments were carried out on particles formed with the double-tail 
surfactant DDAB [54]. The examination of the DDAB-DNA gel particles with the 
DNA-selective dye AO revealed the formation of spherical domains on the surface of 
these DDAB-DNA gel particles (Fig. 5a). The nature of these domains was studied 
using the hydrophobic dye Nile Red (NR) (Fig. 5b) [82]. The fluorescence emission of 
NR, in the presence of DDAB-DNA gel particles, was nearly identical to that recorded 
for DDAB vesicles (results not shown). This indicates that the observed spherical 
domains on the surface of the DDAB-DNA gel particles are composed of hydrophobic 
layers of the surfactant. SEM experiments also confirm the presence of these spherical 
domains (Fig. 5c).  
 Differences in the reorganization of DNA were found as a function of the secondary 
structure using both FM and SEM.  In the case of particles formed with native DNA, 
the observed vesicular domains seem to have grown by fusion of several vesicles, 
adopting a near-spherical shape. However, the greater thickness of the vesicular 
domains found in the DDAB–ssDNA particles suggests that the reorganization of 
DDAB vesicles in the presence of denatured DNA takes place with the subsequent 
formation of multilamellar complexes. Although these DDAB–DNA particles were 
prepared at the same DNA/DDAB ratio, the results indicate that differences in local 
DNA concentration or some kind of inaccessibility of one of the components can be 
significant. FM images at higher magnification also support these differences.  
[Fig. 5 here] 
 
3.3. Swelling/dissolution behaviour and kinetics of DNA release 
 Gels are considered to have great potential as drug reservoirs. Loaded drugs can be 
released by diffusion from the gels or by gel erosion. When the DNA gel particles are 
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inserted into a certain medium, different responses occur: swelling or deswelling, 
dissolution, and release of DNA. 
The swelling protocol begins when the initial weight (Wi) of the particles prepared 
under each condition was measured immediately after were prepared, separated by 
filtration and washed with pH 7.4 PBS to remove excess of salt. Particles (around 100 
mg) were exposed to the initial PBS buffer at an agitation rate of 30 rpm and at room 
temperature, using a shaking platform. Additionally, the wet particles were measured at 
each time point (Wt) immediately upon removal of the release solution. Then, fresh 
solution was added in order to maintain a clean environment. The swelling ratio of the 
particles at each time point was calculated accordingly from the following equation: 
Relative weight (RW) = Wt / Wi        
This value reflects the change in weight of the particles at each time point with respect 
to the initial weight of the gel. Complete degradation of a particle sample was noted 
when the presence of the particles or fragments of them were no longer visually 
apparent. 
Simultaneously to the studies of swelling/dissolution behaviour, DNA release studies 
were carried out. The release solution was completely removed from the samples and 
completely replaced with fresh solution at periodic time points. The amount of DNA in 
the release solutions was quantified by measuring the absorbance at 260 nm. The 
cumulative DNA release was normalized with respect to the initial weight particle and 
expressed as percentage.   
 In the case of surfactant-DNA gel particles, the extension of the swelling process 
depends on the surfactant structure (Fig 6a). For the same hydrophilic contribution 
(CTAB and DTAB), the decrease in the number of carbon atoms from sixteen to twelve 
in the hydrophobic chain contributes negatively to the swelling extent. So, when CTAB-
DNA gel particles were placed in pH 7.6 10 mM Tris HCl buffer, water was taken up 
from the medium and swelling could be observed. The swelling continued during the 
entire time interval studied (1,200 h) [53]. However, DTAB–DNA particles showed an 
initial swelling and then dissolved completely after 48 h [54]. 
 Generally, the DNA release pattern resembles that observed in the 
swelling/dissolution profiles. Thus, CTAB-DNA particles placed in pH 7.6 10 mM Tris 
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HCl buffer showed no initial burst release (Fig.7a). After 1,200 h, 69 % of DNA was 
released from the particles [8]. Nevertheless, DTAB–DNA particles exhibited fast 
release behaviour by a dissolution mechanism. The corresponding half-life of DTAB–
dsDNA is 4. After 24 h, more than 97% of the bound DNA was released [54]. 
 For the same hydrophobic contribution (ALA and LAM derivatives), the 
swelling/dissolution behaviour can be modulated by modification of the type and 
number of positive charges on the polar head [55]. Particles containing ALA exhibited 
the largest (relative weight ratio, RW 2.5) and the longest (more than 1,300 h) swelling 
process. Particles containing LAM swelled (RW 2.0 using the maximum points as 
estimate) for up to 200 h, and then started to shrink. More stable particles were obtained 
for ALA than for LAM, probably due to its double charge. Thus, LAM-DNA particles 
exhibited faster release than ALA-DNA particles (Fig. 7a). Complete release from 
LAM-dsDNA particles occurred after 400 h. When the formulation contained ALA, the 
DNA release was slower. Complete DNA release was only achieved after 1800 h. The 
results suggest that, for the same hydrophobic contribution, the stability of the gel 
particles is additionally given by the electrostatic interaction between DNA and the 
oppositely charged surfactant. 
 Furthermore, the increase in the number of alkyl chains from one to two (DDAB) 
contributes positively to the stabilization of the particles [56]. DDAB-DNA particles 
absorbed an amount of water that was twice the initial mass (relative weight, RW, of 2, 
using the maximum points as an estimate). These particles had returned to the original 
particle weight by the end of the experiment (1,500 h). In the case of DNA gel particles 
formed using the double-tail surfactant DDAB, an initial burst release was observed 
(Fig 7a). The amount of DNA released in the first 24 h was 44% for DDAB–dsDNA 
particles. The presence of this burst suggests that some DNA is not encapsulated, or 
DNA is bound weakly on the surface of the particles. From 24 to 600 h, a plateau was 
observed in the cumulative DNA release. After that, particles placed in the buffer 
solution showed a change in release kinetics. A linear cumulative release was observed 
until the end of the experiment (1,500 h). The amount of DNA released from DDAB–
dsDNA was 63%. 
 Concerning protein-DNA gel particles, LS-dsDNA gel particles lost weight rapidly 
and extensively (Fig. 6b) [63]. In the case of PS-dsDNA particles, the largest relative 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
15 
 
weight ratio was observed (RW>5). For the high LS/PS ratio, particles absorbed a water 
amount of 2-3 times the initial mass (relative weight ratio, RW, of 2-3) during the 
swelling process. With a decrease in the LS/PS ratio, more moderate absorption of 
water was observed (RW=1-2). When the particles contained PS, there was a common 
trend in the swelling profiles, in which initial swelling was visible before the particle 
started to dissolve. The initial period in the swollen state, before dissolution takes place, 
was independent of the PS content and lasted approximately 100 h (using the maximum 
of the first peak as an estimate). Then, a short period of stabilization was observed after 
a new, more limited, maximum appeared (located around 400 h). Thereafter, the RW 
value became approximately constant, with two exceptions. For PS-dsDNA particles, 
RW increased with time, while for the LS-PS15 system, nonmonotonic behaviour was 
observed. 
 LS-dsDNA particles exhibited fast burst release behaviour by a dissolution 
mechanism (Fig. 7b). After 24 h, 84% of the bound DNA was released. When the 
formulation contained PS, the initial burst release was absent. The percentage of DNA 
released in the dissolution media, after 24 h, varied from 0.4 to 1.0% for protein mixed 
systems. The absence of a burst effect suggests that minimal amounts of unencapsulated 
DNA are present on the surface of the particles after their formation. For particles 
containing both proteins, the profiles showed slower DNA release than in the pure 
systems. The release rates remained almost constant in the case of particles formed at a 
high LS/PS ratio (LS-PS15 and LS-PS30). However, with a decrease in the LS/PS ratio, 
a sudden acceleration of the release was observed after ≈400 h. We can assume that 
complete hydration of the core in our particles could occur after 400 h, taking into 
account the presence of the maximum RW values in the swelling-dissolution 
experiments (Fig. 6b). This matrix swelling behaviour could determine the change in 
the rate of DNA release, which became dependent on the LS/PS ratio. In addition, the 
final release percentage was largely dependent on the LS/PS ratio. As indicated by the 
arrow in Fig. 6, the formulations with the lowest PS content released only a small 
percentage of the DNA present in the particles (<20%), but this percentage increased 
with PS content to attain ca. 80% for the LS-PS85 formulation. 
 The determination of the kinetics of swelling and dissolution behaviour 
demonstrated that chitosan-DNA gel particles lost weight rapidly and extensively (Fig. 
6c). The molecular weight of chitosan has a significant effect on the encapsulation of 
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DNA and on the in vitro release properties. The release of DNA from the different 
particles is illustrated in Fig. 7c. Generally, DNA release rates in the initial period were 
high in all cases. In the first 24 hours, 57%, 71%, and 74% of DNA were released from 
the particles containing low MW chitosans of ca. 50 kDa and 150 kDa, and medium 
MW chitosan (400 kDa), respectively [74]. 
[Fig. 6 here] 
[Fig. 7 here] 
 
3.4. Surface hydrophobicity evaluation of DNA gel particles 
Surface properties of carriers determine their physicochemical characteristics and 
fate in blood circulation [83]. Information about surface properties is of high relevance 
for carriers, especially for those intended for parenteral delivery. Hydrophobicity of the 
particle surface governs the adsorption of plasma proteins [84] and subsequently the rate 
of clearance from systemic circulation. These parameters also influence the overall 
bioavailability of the drug/ gene delivered by the tested nanocarrier. 
The hydrophobicity of a particle surface has been shown to influence not only the 
amounts of protein bound to the particle, but also the identities of the bound proteins 
[85]. The number of proteins bound to the particles increased with increasing 
hydrophobicity of the particle surface, as well as with increasing size. Generally, 
hydrophobic particles are opsonized more quickly than hydrophilic particles, due to the 
enhanced absorbability of plasma proteins onto the surface of hydrophobic particles 
[86-89]. The roles of particle size, surface curvature, and particle surface area in protein 
binding have also been investigated. Investigators have shown that, the amount of 
bound protein varied with size and surface curvature. However, the protein pattern was 
the same for all sizes considered [90]. Though particle composition (base material type, 
shape, and size) clearly influences protein binding, the surface properties (charge and 
hydrophobicity) are likely to be more important. 
There are only a few ways to measure or compare the hydrophobicity of surfaces in 
disperse systems. Contact-angle measurements cannot be applied to the hydrated 
colloidal particle in its original dispersion medium. Polymer particles need to be 
dissolved in an organic liquid to cast the polymer film for the contact-angle 
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measurements. The properties of the dry polymer film certainly differ from the 
properties of a strongly curved surface; therefore, it is insufficient to determine only the 
contact angle on macroscopic surface with conventional measurements. In the last few 
years, the determination of the so-called surface hydrophobicity of colloidal particles 
and biopolymers has been improved [91]. In this set of experiments, the adsorption of 
hydrophobic yet soluble organic dyes onto different polymer lattices has been 
investigated. The measurements have been conducted using a UV-VIS spectrophometer. 
The advantage in measuring in the visible spectrum is that impurities (surfactants, 
monomers) released by the colloidal particles over time do not disturb the spectrum of 
the dyes. Rose Bengal (RB) partitioning method was developed as an easy and quick 
method to estimate the surface properties of uncoated polymer nanoparticles [92]. Rose 
Bengal is a xanthenes dye used as photosensitizer, fluorescent label and as adsorption 
marker [91, 93].  
The first approach on the determination of the superficial hydrophobicity of DNA 
gel particles have been carried out on DNA gel particles formed by mixing DNA with 
chitosan lactate (CL) (binary systems) or CL in combination with the protein protamine 
sulfate (PS) (ternary systems) [75]. For this purpose, the RB adsorption on the CL-DNA 
gel particles prepared at different ratio R values was studied. The quantity of free RB in 
the solution was determined by interpolation from a calibration curve. The 
concentration of RB bound to the particle surface was calculated as the difference 
between the total concentrations of RB used in the assay and free RB. The obtained data 
were transformed to the adsorption isotherms (Γ), which is correspond to the RB bound 
as a function of the particle weight , in respect to the RB at the equilibrium (free RB). 
Fig. 8a shows the evolution of the adsorption isotherms as a function of the ratio R 
values. All DNA gel particles were formulated using the method of simple 
complexation between molar concentrations of negative charge of the phosphate groups 
of DNA, and the positive charge of the cationic compound. Particles were formed at 
specific R ratio, where R=[DNA]/[C
+
]. In the case of binary systems, R values varied 
between and 39.6 and 1, where [DNA] and [C
+] 
are expressed in % (w/v). In the case of 
ternary systems, particles were prepared at a ratio R equal to 1, where [C
+
] is the 
concentration of the corresponding cationic system, expressed in % (w/v). The 
composition of the mixed systems was varied between 15 and 85% PS. In all cases 
[DNA] was equal to 2 % (w/v).  
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Due to the relative fragility of the CL-DNA particles prepared at R=7.92, there were 
not enough individual particles to carry out these experiments. In general, it can be 
deduced that the maxima of RB adsorption increases when the R value is decreased. 
The shape of the isotherms is not sophisticated at all, showing the decay of the 
adsorption at higher equilibrium concentrations. This decay is mainly observed for the 
systems prepared at lower R values, for which higher concentration of CL on the 
particles is expected. The observed decay on the adsorption isotherms can be correlated 
with the aggregate formation of the dye as have been observed in the case of RB with 
cationic surfactant molecules [94]. Similar experiments were carried out with the 
CL/PS-DNA gel particles prepared at different composition (Fig. 8b). Due that the 
particles formed with pure PS exhibit a strong tendency to aggregate; no RB adsorption 
experiments were carried out with this pure protein system. In general, it can be 
deduced that the RB adsorption increases when the percentage of PS in the composition 
are increased. The decay of the RB adsorption at higher equilibrium concentrations 
becomes less important when the percentage of PS in the composition is increased.  
Taking into account the Γmax value, the relative hydrophobicity of these DNA gel 
particles has been established (Fig. 8c)  It is expected that the higher the Γmax value, the 
higher is the relative hydrophobicity. The obtained results suggest that the surface 
hydrophobicity of the particles using binary systems is a function of the R values, 
increasing when the concentration of CL is increased. On the ternary systems, the 
surface hydrophobicity of the particles is a function of the composition, increasing when 
the concentration of PS on the mixtures is increased.   
Due that the obtained results suppose the first approach on the determination of the 
superficial hydrophobicity of DNA gel particles, in order to grade their relative 
hydrophobicity, these values have been compared with other described in the literature, 
in which the Γmax values of several polymer lattices have been shown [91]. Particles 
derived from polystyrene, which presents a strong hydrophobic character showed Γmax 
values close to 0.072 mmol g
-1
. On the other hand, Γmax values for poly(methyl 
methacrylate) particles, that present a hydrophilic character, were found to be 0.017 and 
0.037 mmol g
-1
, depending on the ionic character. Considering those values, it can be 
deduced that particles obtained using both ternary and binary systems showed a strong 
hydrophilic character with Γmax values ranged between 5x 10
-4
 - 2.84x 10
-3
 mmol g
-1
,
 
and 9.1x 10
-5 
- 5x 10
-4
 mmol g
-1
, respectively. The acute hydrophilic character of these 
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DNA gel particles may govern the posterior adsorption of plasma proteins and influence 
the overall bioavailability of the system.  
[Fig. 8 here] 
4. Determination of in vitro biocompatibility 
At a consensus conference of the European Society for Biomaterials in 1986, the 
word “biocompatibility” was defined as “the ability of a material to perform with an 
appropriate host response in a specific application”. With the rapid development of 
biomaterials, the scope of “biocompatibility” has been widely broadened. Herein, we 
use biocompatibility to include the deleterious effects caused by the DNA gel particles, 
covering the in vitro haemolytic and cytotoxic assessments. 
4.1. Haemolysis 
 
An important feature in the development of particulate systems for parenteral 
administration is to determine their ability to cause haemolysis by interaction with the 
cell membrane.
 
The potential uses of colloidal self-assemblies as drug delivery systems 
make haemolysis evaluation very important. To this end, we examined this interaction 
by using erythrocytes as a model biological membrane system, since erythrocytes have 
been used as a suitable model for studying the interaction of amphiphiles with 
biological membranes [95-97]. Most in vitro studies of surfactant-induced haemolysis 
evaluate the percentage of haemolysis by spectrophotometry, to detect plasma-free 
haemoglobin derivatives after incubating surfactant solutions with blood and then 
separating undamaged cells by centrifugation. However, in the case of particles, the 
interpretation of the results of these studies is complicated, due to the variability of 
experimental approaches and a lack of universally accepted criteria for determining test-
result validity. 
The first approach on the determination of the haemolytic response of DNA gel 
particles have been carried out on DNA gel particles formed by mixing DNA (either 
single- (ssDNA) or double-stranded (dsDNA)) with different single-chain surfactants 
whose structure differs only in the corresponding counter-ion [54]. First of all, the 
haemolytic potency of the different components was determined separately. The 
dependence of haemolysis on the concentration of the surfactant is shown in Fig. 9a. In 
this experiment, haemolysis was determined at a fixed time, after 10 min incubation in 
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the presence of various surfactant concentrations. Haemolysis varied with the surfactant 
concentration in a sigmoidal manner. At concentrations below 300 µg mL
-1
, for DTAB 
and DTATf surfactants, the percentage of haemolysis was not significant (below <5 %), 
which can be regarded as a non-toxic effect level. However, it increased sharply 
between 400 and 600 (or 700 µg mL
-1
, depending on the surfactant structure) to reach 
essentially 100% haemolysis at that concentration. The concentrations assayed were 
well below 4,000-4,500 µgmL
-1
, which corresponds to the CMC (Critical Micelle 
Concentration) value of the surfactants, as previously determined (5. 0 mM DTATf 
[98],
 
15.0 mM DTAB [99], 20.0 mM DTAC [100]). The sigmoidal pattern of this DTA–
induced haemolysis is indicative of a complex process in which sufficient surfactant 
needs to accumulate in the target membrane to induce the osmotic lysis of erythrocytes. 
The HC50 values for the different surfactant structures are 443, 468 and 510 µg mL
-1
 for 
DTAC, DTATf and DTAB, respectively. The haemolytic potency of the DNA was also 
determined. As expected, DNA showed no haemolytic activity.  
[Fig. 9 here] 
One drawback of these surfactant-DNA gel particles, in toxicological terms, is the 
need for a cationic surfactant, which may cause some cellular damage. Our results 
indicate, however, that the effect of the surfactant can be modulated when administered 
in the DNA gel particles, unlike what happens in aqueous solution. This modulation is 
due to the strong interaction between the surfactant and the biopolymer, which leads to 
a very slow release of the surfactant from the vehicle. Accordingly, although the HC50 
values for these three surfactants are very close in aqueous solution, strong differences 
were found when the haemolysis kinetics of the corresponding surfactant-DNA gel 
particles was determined, as represented in Fig. 9b and Fig. 9c. As the haemolytic 
character of these surfactants in solution is almost identical, the differences found in the 
haemolysis responses induced by the different surfactants in the DNA particles can only 
be related with the capacity to form weaker or stronger surfactant-DNA complexes. It is 
then expected that for a higher degree of complexation, less surfactant, which could 
interact with the erythrocytes membrane, would be released in solution.  
This trend in surfactant-DNA interaction reflects both the release of haemoglobin 
(degree of haemolysis) and the release of DNA into the media, as a consequence of 
different dissolution kinetics of the polyelectrolyte-surfactant complexes. Under the 
experimental conditions in which the haemolysis studies were carried out, dsDNA-
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surfactant particles were fully dissolved by the end of the experiments. However, 
ssDNA-surfactant particles remained visible in the dispersion. Here, for the first time, 
both parameters were determined simultaneously, giving us information about the 
effectiveness of the two release processes. Fig. 10 shows the relative kinetics of DNA 
and haemoglobin release. 
[Fig. 10 here] 
The amount of DNA that is released and the haemolytic response are strongly 
dependent on both the structure of the counter-ion in the surfactant and the secondary 
structure of the DNA. In the case of particles prepared with native DNA, the amount of 
dsDNA that is released at the end of the experiment (180 min) reaches 100 µg mL
-1
 
(Fig. 10a). However, with particles prepared with denatured DNA, only 10% of this 
amount is released into the media (Fig. 10b). This behaviour, which can be correlated 
with the degree of complexation, is higher in the case of ssDNA, thus decreasing the 
amount of non-complexed DNA that could be detected in solution. These differences 
are also supported by visual inspection: surfactant-dsDNA particles are completely 
dissolved at the end of the experiment, whereas surfactant-ssDNA particles are still 
present after 180 min.    
At this point, it is possible to establish which of these systems is the most 
haemocompatible. For this, the haemolysis values for a defined amount of released 
DNA are compared. In the case of the surfactant-dsDNA particles, for a concentration 
of dsDNA equal to 100 µg mL
-1
, the degree of haemolysis is 30%, 60% and 80%, when 
DTATf, DTAC and DTAB are used as cationic agents, respectively. In the case of 
surfactant-ssDNA particles, and for a concentration of ssDNA equal to 5 µg mL
-1
, the 
degree of haemolysis is 20%, 50% and 70%, when DTATf, DTAC and DTAB are used 
as surfactants, respectively. The haemolysis response found in these DNA gel particles 
can be correlated with differences in the apparent degree of counter ion dissociation in 
these surfactants from the corresponding micelles [98-100].  
 
4.2. Cytotoxicity 
 
Cytotoxicity plays a critical role in the efficiency of the delivery vectors. In order to 
deliver the DNA into the cells, the cationic particles bind to the cell surface by 
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electrostatic interaction, promote endocytosis and release the genetic material inside the 
cell. Unfortunately, while high concentrations of the delivery agents imply an increased 
chance of the DNA penetrating the cell nucleus, they can also interfere with 
physiological processes within the cell, inducing cell death. Thus, present research is 
aimed at designing gene delivery agents that are able to deliver DNA into the cells with 
minimal toxicity [101].   
Despite the significant scientific interest and promising potential of the particulate 
materials, the safety of these systems remains a growing concern, considering that 
biological applications of particles could lead to unpredictable effects.  Currently, there 
are no specific testing requirements for nanotechnology products, and therefore, 
researchers took liberal approaches to studying toxicity [102-103]. Moreover, it is worth 
noting that, because of the expense of animal testing in toxicology and pressure from 
both the general public and government to develop alternatives to in vivo testing, in 
vitro cell-based models may be more attractive for preliminary testing of nanomaterials 
[104]. The prediction of toxicity is difficult, but cytotoxicity screening, which is 
routinely used in drug screening, gives a good indication of potential adverse effects in 
cells. Rapid, sensitive and reliable bioassays are required to examine the toxicity. 
Established cell lines are useful alternative test systems for this kind of toxicological 
studies [105]. However, they must be chosen with care with regard to their origin [106].
 
Cytotoxicity assays are among the most common in vitro endpoints used to predict the 
potential toxicity of a substance in a cell culture [107]. Cell damage is manifested in 
several ways, including mitochondrion and plasma membrane dysfunction and 
fluctuating intracellular reduction capacity [108.Current standard approaches to gauge 
the degree of cell damage include assays that measure various aspects of cell viability, 
such as metabolic activity and plasma membrane integrity. The MTT reduction assay 
which is based on the reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazoliumbromide by cellular dehydrogenases, is among the most commonly 
used endpoints. This method measures the reduction of MTT salt to a coloured 
insoluble formazan in active mitochondria in viable cells and also, in certain cases, 
outside the mitochondria [109-110].  
The first approach on the determination of the cytotoxic response of DNA gel 
particles have been carried out on protein-DNA gel particles formed using two different 
approaches by mixing double-stranded DNA (dsDNA) with lysozyme (LS) and 
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protamine sulfate (PS) mixtures. The interaction of these protein-DNA gel particles and 
their components with non-tumour (3T3 fibroblast) and tumour (HeLa) cell lines has 
been determined, using the imposed variations in protein composition and the size of 
the final particles, as a consequence of the different preparation method, as controlling 
parameters [64].  
Assessing the capacity of live cells to metabolise a tetrazolium colourless salt to a 
blue formazan (MTT assay) were used to perform indirect measurements of cell 
viability. Dose–response curves for each protein, determined by MTT assays using 
tumour cell line HeLa and non-tumour cell line 3T3 fibroblasts, are given in Fig. 10. 
The cytotoxicity assays were performed in the concentration range 50 and 2000 μg   
mL
-1
. Although it is thought that proteins are biocompatible and nontoxic compounds, 
our results have revealed that, as with other cationic derivatives, LS and PS displayed 
concentration-dependent toxicity towards cells in vitro. LS showed low cytotoxicity 
towards 3T3 cells, which displayed viability in the range 81% to 100% as determined 
by the MTT assay (Fig. 11a) at the tested protein concentration range. In the case of PS, 
viability changed from 7% to 100% depending on the concentration. These experiments 
enabled us to define the protein concentration required to inhibit cell growth by 50% 
compared with an untreated control (IC50). In the case of LS, its IC50 was found to be 
higher than 2000 µg mL
-1
 in both cell lines. For PS, it was found to be 140 and 250 µg 
mL
-1
 for 3T3 and HeLa cell lines, respectively (Fig. 11b). These differences could be 
attributed to differences in the binding characteristics of these two proteins, with 
different total charge and linear charge density: LS is a globular protein that has a net 
charge of + 9 at neutral pH, whereas PS is a highly positively charged linear protein 
with an overall charge of +21. 
 [Fig. 11 here] 
  Cell culture studies have greatly increased the understanding of cellular functions and 
complex signalling pathways and have been routinely used for toxicity screening of new 
compounds. Based on the assumption that a decrease in cellular vitality reduces physiological 
function, cellular products and cell number, cytotoxicity screening assays that measure 
enzymatic activities or cell products have been carried out. These assays perform reliably with 
chemical compounds but can produce false results by interference with particulate systems. 
Most examples have been published for the MTT assay. Nanomaterials interfere with the assay 
by light absorbance, reduction of the tetrazolium salt, and binding of the formazan salt [111]. 
AC
CE
PT
ED
 M
AN
US
CR
IP
T
ACCEPTED MANUSCRIPT
24 
 
Interactions of nanomaterials assays include interference by adsorption of dyes [112], 
absorbance [113], fluorescence [114], binding of proteins [115], dye degradation [116] and dye 
formation [112], among others. 
In each of these cases the underlying phenomena involve some interaction between 
nanomaterials and organic small-molecule solutes in multicomponent biological phases. 
Less attention has been paid to the fundamental interactions of nanomaterials with small 
biomolecules in complex physiological fluid phases. Inspired on the observation that 
small quantities of nanotubes removed the colour associated with the pH indicator dye, 
phenol red, in cell culture medium [117], it has been described that nanotube adsorption 
causes profound changes in the composition of the medium, and thus has the potential 
to influence in vitro cell behaviour through an indirect mechanism that does not involve 
physical interaction between nanotubes and target cells [118].  
Previous studies in our laboratory have verified the absorption of the culture media 
by the particles when 3T3 and HeLa cell lines were incubated in the presence of some 
surfactant-DNA gel particles prepared by the dropwise addition method. In this case, the 
obtained cell viabilities were close to 5% (results not published). Although the IC50 
values of the corresponding surfactants in solution were not very high (with values 
around 10 µg mL
-1
), this low cell viability may be correlated with the physicochemical 
properties of these DNA gel particles. Even though no systematic studies on the 
composition of the medium have been carried out, the observed swelling behaviour of 
some of these DNA gel particles point out the effect of adsorption of essential 
micronutrients from cell culture medium. Therefore, toxicity data must be interpreted in 
the context of the physicochemical characteristics of the particulate systems.  
Concerning the protein-DNA gel particles prepared by the dropwise addition method, 
visual inspection of the corresponding plates exhibited no evident changes on the 
volume and characteristics of the culture media when 3T3 and HeLa were incubated in 
the presence of individual protein-DNA gel particles during 24h. Although these 
particles are several magnitudes larger than cells and cannot be internalized as a whole, 
this study demonstrates that the physicochemical properties of these protein-DNA gel 
particles may not affect their cytotoxic characterization under standard protocols. As has 
been already pointed, an important implication of the changes in the composition of the 
medium, as assessed by commonly used endpoints, such as cell viability, DNA damage, 
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and apoptosis, may be mistakenly attributed to direct toxicity when in fact it is a 
secondary effect of adsorption of essential micronutrients from cell culture medium. 
Cell viabilities of up to 80% were observed in almost all compositions when the 
cytotoxicity of the corresponding protein-DNA gel particles was determined in both cell 
lines (Fig. 12a). However, cell viabilities were always lower than 10-20% when cells 
were incubated in the presence of pure and mixed protein solutions (Fig. 12b).  
[Fig. 12 here] 
In previous studies in our lab, we have prepared nano-/micro-sized DNA gel particles 
by nebulisation of DNA solutions (either single- (ssDNA) or double-stranded (dsDNA)) 
into an oppositely charged surfactant or protein solution [77].
 
FM studies suggest that 
the formation of the particles was carried out with conservation of the secondary 
structure of the nucleic acid molecules. SEM on freeze-dried and Au-shadowed samples 
showed a distribution of virtually spherical particles. It was found that, in addition to the 
size of the initial DNA droplets, the cationic agent is a controlling parameter of the 
particle size. In the case of protein- NA gel particles, LS-DNA gel particles showed 
diameters around 10 µm whereas the size of PS-DNA was around 400 nm (see Table 2).  
In a recent study, small-sized mixed protein-DNA gel particles were prepared for the 
first time, and their cytotoxicity was evaluated. Although the particle dispersions were 
studied without further purification, and both free protein and protein-DNA gel particles 
were present in the obtained dispersions, the cytotoxic responses shown in Fig. 13a 
were observed to be significantly different to that observed with proteins in solution 
(Fig. 13b). As expected, the cytotoxicity of the obtained DNA particles resulted lower 
than that observed with the corresponding protein in solution. Only the LS system 
showed an irregular behaviour. 
 
[Fig. 13 here] 
The observed differences in cytotoxicity may be correlated with differences in 
protein-DNA complexation in these systems. Consequently, we determined the initial 
amount of protein in the media, as well as the amount of protein remaining in the 
dispersion containing the protein-DNA gel particles formed by the nebulisation method. 
From these values, the degree of complexation in the different systems was determined. 
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Fig. 13c shows the evolution of the degree of complexation according to the LS/PS 
ratio. In the case of the protein-DNA gel particles, it was expected that the higher the 
degree of complexation, the smaller the amount of protein that would be released in 
solution, an amount which would be able to interact with the cells and reduce their 
viability. Independently of the cell line response, the differences in the degree of 
complexation were in agreement with the observed trend in cell viabilities (Fig. 13d). 
Differences in cytotoxicity between protein-DNA particles prepared by the dropwise 
addition method and the nebulisation method could be related to differences in the 
kinetics of dissolution/release profiles. Studies of DNA release from protein-DNA 
particles formed by the dropwise addition method have demonstrated that these particles 
can present DNA release profiles of up to 1,000 h, confirming the stability of these 
protein-DNA gel particles [63]. In the present study, the stability of these particles in 
the culture medium was also confirmed. Supported by visual observation, the particles 
remained present in the well plate after 24h of incubation. This behaviour and the fact 
that the observed cytotoxicity was almost independent of the protein composition (Fig. 
12a) corroborate this argument. Although the profiles of dissolution/release of the 
protein-DNA gel particles prepared by the nebulisation method have not yet been 
determined, it is expected that smaller particles will show faster dissolution profiles. As 
a consequence of the protein release, a more composition-dependent cytotoxic response 
compared with that observed at large-sized particles could be awaited. In the case of 
these small-sized protein-DNA particles the cytotoxic responses were strongly 
dependent on the protein composition (Fig.13a).   
The preparation of the protein-DNA gel particles by the nebulisation method enabled 
us to obtain particle dispersions in order to evaluate the effect of the concentration (in 
this study, expressed as protein concentration). Observation of IC50-values showed that 
the two cells lines were markedly different in sensitivity to the cytotoxic effects of these 
protein-DNA particles (Fig. 14 and Table 3). Except in the case of the pure systems, 
which displayed identical cytotoxicity in both cell lines, the tumour cell line HeLa was 
more sensitive to the deleterious effects of the mixed protein-based particles than 3T3 
fibroblasts (significant differences between 3T3 and HeLa for the same conditions are 
indicated in Table 3 with an asterisk). Consequently, the mixing of proteins had a clear 
modulating effect on the relative cytotoxicity of these systems towards tumour and non-
tumour cell lines.  
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[Fig. 14 here] 
 
5. Summary 
A general understanding of interactions between DNA and oppositely charged 
agents provides a basis for developing novel DNA gel particles. The adsorption 
strength, which is tuned by varying the structure of the cationic agent, allows the control 
of the spatial homogeneity of the gelation process, producing either a homogeneous 
DNA matrix or different DNA reservoir devices. It was shown that DNA was 
effectively entrapped in the assayed cationic surfactant, protein and polysaccharide 
solutions, protecting its secondary structure. When the DNA gel particles are inserted in 
a medium, different responses occur: swelling or deswelling, dissolution, and DNA 
release. Controlling the magnitude of the DNA release and achieving controlled release 
systems was accomplished by changing the composition in the cationic solutions where 
particles were formed. Modulation of the superficial hydrophobicity of the DNA gel 
particles, as a consequence of the imposed compositions, may govern the posterior 
adsorption of plasma proteins and influence the overall bioavailability of the systems.  
One drawback of the DNA gel particles, in toxicological terms, is the need for a 
cationic compound, which may cause some cell damage. However, our results indicate 
that the effect of the cationic agent can be modulated when administered in a DNA gel 
system, rather than in an aqueous solution. Unlike delivery in an aqueous solution, the 
cytotoxicity of the cationic system can be reduced when the opposite charges between 
the cationic compounds and DNA spontaneously result in complexation due to 
electrostatic interactions. The magnitude of DNA entrapment can be controlled and 
controlled release systems achieved through the formation of a DNA-oppositely charged 
complex network giving rise to these DNA gel particles. The decrease in toxicity as 
well as the formation of a releasable high DNA content reservoir renders these DNA gel 
particles promising DNA vehicles for use as a nonviral gene delivery system.  
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6. Prospects  
Over the last two decades, gene therapy has brought human medical prospect into a 
new phase, whereby genetic defects on cells can be regulated and also a range of 
diseases can be prevented. DNA-based molecules are being employed to prevent, treat, 
and cure diseases by changing the expression of genes that are responsible for the 
pathology. Since its inception, plasmid-DNA-mediated gene therapy has seen 
significant growth and brings fruitful clinical trials. However, the major underlying 
challenge is the development of a carrier system that must have the capacity to enter the 
cells of interest, to protect nucleic acids from nuclease degradation, to escape the 
endocytic pathway and reach the cytosol, to dissociate and release the DNA, and to 
facilitate the integration and activity of the transferred DNA inside the nucleus. In the 
absence of cell division, and additional limiting step is the translocation of DNA 
through the nuclear envelope. Some recent works have turned to investigate the nucleus 
entry problem [119]. Evidently nuclear pore complexes (NPC) act as gateway for 
macromolecular traffic between the cytoplasm and the nucleus. Short nucleic acids such 
as oligonucleotides can diffuse freely through the pore. Larger molecules need to be 
actively transported by a cargo protein that carries a nuclear nuclear localization signal 
(NLS). Endogenous nuclear proteins, whose natural functions are to condense DNA and 
which possess one or more NLS sequences, are interesting candidates to mediate 
nuclear translocation. Among these are proteins from the high mobility group (HMG), 
histones (especially H1), and protamines that were shown to enhance in vitro 
transfection efficiency properties [120-122]. We are engaged in current work focusing 
on the use of nuclear protein on the formation of DNA gel particles based on associative 
phase separation and interfacial diffusion [123]. 
 An alternative promising approach comes from the observation that 
glycoproteins lacking NLS are able to enter the nucleus. Oligosaccharides are 
presumably recognized by lectins (a component of the nuclear pore complex). If bound 
to DNA, these oligosaccharides can facilitate its transport through the nuclear envelope. 
Recent research has been focused on the application of the pure chitosan 
oligosaccharide lactate or in combination with protamine sulfate as promising DNA 
carriers [75].  
Colloidal carriers have offered the opportunity to design surface properties to enable 
them traverse biological barriers such as skin, mucous barriers, and leaky vasculature. 
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The smart design of the colloidal carrier can protect DNA-based molecules from 
deleterious degradation, and may provide sustained release of payload in a 
therapeutically advantageous fashion. Although these carriers may offer various 
advantages over conventional drug-delivery systems, their safety should not be ignored. 
The toxicity of these nanomaterials may be due to their large surface area. A continuous 
effort focused on improving safety, feasibility, and efficacy of colloidal carriers for 
DNA gene therapy is required. 
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TABLES 
 
Table 1 
Characteristics of the obtained DNA gel particles (see abbreviation list). 
 
Cationic agent Nucleic acid type 
 
Reference 
 
dsDNA ssDNA 
 
 
SINGLE-TAIL SURFACTANT  
CTAB x x [52, 53] 
DTAX x x [54] 
ALA, LAM x x [55] 
DOUBLE-TAIL SURFACTANT  
DDAB x x [56] 
PROTEIN  
LS, PS x  [52,63] 
POLYSACCHARIDE  
CHIT x  [74] 
CL x  [75] 
MIXED SYSTEMS  
LS/PS x  [63, 64] 
CL/PS x  [75] 
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Table 2 
Mean size of DNA particles systems determined by photon correlation spectroscopy 
(including polydispersity index, P. I.). 
 
System Mean size  
(nm) 
P. I. 
CTAB-dsDNA 139 ± 8 0.46 ± 0.09 
CTAB-ssDNA 126 ± 1 0.40 ± 0.01 
PS-dsDNA 387 ± 81 0.78 ± 0.03 
PS-ssDNA 343 ± 10 0.14 ± 0.03 
LS-dsDNA 9200 ± 2800 0.31 ± 0.40 
LS-ssDNA* 9450 ± 2000 0.78 ± 0.50 
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Table 3 
Cytotoxic properties of the protein-based DNA carrier systems prepared by the 
nebuliser method. Note that the IC50 values are given in terms of protein concentration 
(mM). *Significantly different at p<0.05  
 
 
System 3T3 
IC50 (mM) 
HeLa 
IC50 (mM) 
LS-DNA < 0.16 < 0.16 
LSPS15-DNA > 1.25 0.92 
LSPS30-DNA* > 1.25 0.32 
LSPS50-DNA > 1.25 0.92 
LSPS70-DNA 0.80 0.60 
LSPS85-DNA* 0.75 0.68 
PS-DNA > 1.25 > 1.25 
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FIGURE CAPTIONS 
 
Fig. 1. The formation of DNA gel particles: (a) phase map of the CTAB/dsDNA/water mixture 
a t 25 ºC, where 1Φ and 2Φ indicate the one and two phase regions, respectively and the solid 
line is the boundary between these regions. (x) Gives studied compositions and (○) the area 
where gel particles were observed and (b) the representative morphology of CTAB-dsDNA 
particles. Adapted from reference [52]. 
Fig.2. Characterization of the DNA gel particles with respect to DNA loading efficiency (a), 
loading capacity (b) and DNA complexed (c), as a function of the cationic compound 
(surfactants: light grey bars; proteins: dark grey bars; polysaccharides: black bars). 
Representative images of the obtained DNA gel particles showing translucent or opaque 
particles as a consequence of the characteristics of the gelation process (d). Adapted from 
references [53-56, 63, 74]. 
Fig. 3. Fluorescence microscopy micrographs of individual surfactant-DNA gel particles in the 
presence of the DNA selective dye AO (a). Complexed DNA is related to the amounts of DNA 
in the supernatant solutions and the skins derived from the particles, after particles were 
magnetically stirred overnight (b) Adapted from references [53-55]. 
Fig.4. Scanning electron micrographs of individual CTAB–DNA and DTAB-DNA gel particles: 
outer surface (a) and cross-sections showing both the outer and inner surfaces (b). Adapted from 
references [52, 56]. 
Fig. 5. Scanning electron micrographs (a) and fluorescence microscopy using Nile Red (b) and 
Acridine orange (c) dyes of individual DDAB-dsDNA and DDAB-ssDNA gel particles. 
Adapted from reference [56]. 
Fig. 6. Time-dependent changes in relative weight RW measurements performed on surfactant-
DNA (a), protein-DNA (b) and polysaccharide-DNA (c) gel particles after exposure to pH 7.6 
10 mM Tris HCl buffer solutions. Where Wi stands for the initial weight of the particles and Wt 
for the weight of the particles at time t. Adapted from references [53-56, 63, 74]. 
Fig. 7. Time-dependent changes in DNA release measurements performed on surfactant-DNA 
(a), protein-DNA (b) and polysaccharide-DNA (c) gel particles, after exposure to pH 7.6 10 mM 
Tris HCl buffer solutions. Adapted from references [53-56, 63, 74]. 
Fig. 8. Adsorption isotherms of Rose Bengal onto CL-DNA gel particles as a function of the R 
values. (a), onto CL/PS-DNA gel particles as a function of the protein composition (b) and Γmax  
values of Rose Bengal for these DNA gel particles as a function of the imposed compositions 
(c). Adapted from reference [75].  
Fig. 9. Dependence of rat erythrocyte haemolysis on DTA-based surfactant concentration. 
Erythrocytes were incubated for 10 min at room temperature at different surfactant 
concentrations, and the amount of haemoglobin released was determined (a). DTA-dsDNA (b) 
and DTA-ssDNA particle-induced haemoglobin release from rat erythrocytes as a function of 
time(c). Erythrocytes were incubated at room temperature in the presence of individual DTA-
DNA particles.  The data correspond to the average of three independent experiments ± standard 
deviation. Adapted from reference [54]. 
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Fig. 10. Relative kinetics of DTA-dsDNA (a) and DTA-ssDNA (b) particle-induced 
haemoglobin release from rat erythrocytes and DNA release. Adapted from reference [54]. 
Fig. 11. Concentration-dependent relative viabilities of 3T3 cells (A) and HeLa cells (B) treated 
with LS and PS for 24 h determined by MTT assay. The data correspond to the average of three 
independent experiments ± standard deviation. Adapted from reference [64]. 
Fig. 12. Relative viabilities of 3T3 and HeLa cells treated with individual protein-DNA gel 
particles (a) and the corresponding protein solutions derived from the dropwise addition method 
(b) for 24 h, determined by MTT assay. The data correspond to the average of three independent 
experiments ± standard deviation. *Significantly different (p<0.05) from the corresponding 
protein solution. Adapted from reference [64]. 
Fig. 13. Relative viabilities of 3T3 and HeLa cell lines treated with the protein-DNA gel 
particles dispersion (a) and the corresponding protein solutions derived from the nebulisation 
method (b) for 24 h, determined by MTT assay. In both cases, the assayed concentration was 
1.25 mM, expressed in terms of protein concentration. The data correspond to the average of 
three independent experiments ± standard deviation. * Significantly different (p<0.05) from the 
corresponding protein solution. Complexation stoichiometries of the protein-DNA gel particles 
according to the protein composition(c). Comparison between the complexation stoichiometries 
of the protein-DNA gel particles and the relarive viabilities of 3T3 and HeLa cell lines 
according to protein composition. Adapted from reference [64]. 
Fig. 14. Concentration-dependent relative viabilities of 3T3 (A) and HeLa cells (B) treated with 
the protein-DNA gel particles prepared by the nebulisation method for 24 h, determined by 
MTT assay. The data correspond to the average of three independent experiments ± standard 
deviation. Adapted from reference [64]. 
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Highlights 
►Comprehensive review of DNA gel particles as controlled DNA delivery systems. ► DNA 
gel particles derived from surfactants, proteins and polysaccharides derivatives ► Kinetics of 
swelling or deswelling, dissolution, and DNA release. ► In vitro haemolytic and cytotoxic 
characterization ► Current status and prospects on DNA gel particles are discussed. 
 
